Cargando…

1498. Geographic differences in weight change on dolutegravir: a prospective cohort study

BACKGROUND: People with HIV (PWH) on integrase inhibitors may be at increased risk of excess weight gain, but it is unclear if this risk is consistent across settings. Our study objective was to compare weight change over 48 weeks among PWH in Uganda and South Africa. [Figure: see text] METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Geoffrey, Migisha, Richard, Muyindike, Winnie R, Aung, Taing N, Nanfuka, Victoria, Komukama, Nimusiima, Chandiwana, Nomathemba, Shazi, Gugulethu, Moosa, Mahomed-Yunus S, Gupta, Ravindra K, Pillay, Deenan, Marconi, Vincent, Hedt-Gauthier, Bethany, Francois Venter, W D, Siedner, Mark J, McCluskey, Suzanne M, Manne-Goehler, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678982/ http://dx.doi.org/10.1093/ofid/ofad500.1333

Ejemplares similares

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa
por: Chandiwana, Nomathemba C., et al.
Publicado: (2021)

Postural changes in blood pressure among patients with diabetes attending a referral hospital in southwestern Uganda: a cross-sectional study
por: Migisha, Richard, et al.
Publicado: (2021)

Sydamerika kampen om guld och silver 1498-1600
por: Nordenskiöld, Erland, 1877-1932
Publicado: (1919)

Impact of rilpivirine cross-resistance on long-acting cabotegravir-rilpivirine in low and middle-income countries
por: Steegen, Kim, et al.
Publicado: (2023)

1498. Etiology of Community-acquired Pneumonia in Adults: A Systematic Review
por: Shoar, Saeed, et al.
Publicado: (2020)

Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models
por: Rautenberg, T. A., et al.
Publicado: (2020)

Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa
por: Rautenberg, Tamlyn A., et al.
Publicado: (2023)

VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese
por: Yamamori, Motohiro, et al.
Publicado: (2008)

Characteristics and efficacy of physical activity interventions to improve cardiometabolic and psychosocial outcomes in people living with HIV in sub-Saharan Africa: a protocol for a systematic review
por: Mabweazara, SZ, et al.
Publicado: (2023)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice
por: Peters, Remco P.H., et al.
Publicado: (2022)

Erratum: Southern African HIV Clinicians Society 2022 guideline for the management of sexually transmitted infections: Moving towards best practice
por: Peters, Remco P.H., et al.
Publicado: (2022)

Weight gain on dolutegravir: Association is not the same as causation
por: Maartens, Gary, et al.
Publicado: (2023)

A Detailed Protocol for Characterizing the Murine C1498 Cell Line and its Associated Leukemia Mouse Model
por: Mopin, Alexia, et al.
Publicado: (2016)

Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
por: Phillips, Andrew N, et al.
Publicado: (2018)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
por: Moorhouse, Michelle A., et al.
Publicado: (2018)

Lack of Effect of SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor-2, in a Transgenic Murine Model of Retinoblastoma
por: Cebulla, C.M, et al.
Publicado: (2008)

1498. Assess Risk Factors, Mortality, and Healthcare Utilization Associated with Clostridioides difficile Infection (CDI) in 4 Latin American Countries
por: Yu, Holly, et al.
Publicado: (2019)

High loss to follow-up of children on antiretroviral treatment in a primary care HIV clinic in Johannesburg, South Africa
por: Chandiwana, Nomathemba, et al.
Publicado: (2018)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
por: Kawuma, Aida N., et al.
Publicado: (2023)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
por: Mahomed, Kairoonisha, et al.
Publicado: (2020)

P1498: INHIBITION OF POLYCOMB REPRESSIVE COMPLEX 2 THROUGH EED INDUCES FETAL HEMOGLOBIN IN HEALTHY AND SICKLE CELL DISEASE MODELS
por: Stuart, B., et al.
Publicado: (2022)

P1498: INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
por: Ross, Gayle, et al.
Publicado: (2023)

Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
por: Phillips, Andrew N, et al.
Publicado: (2020)

Evaluation of the Novel Synthetic Tyrosinase Inhibitor (Z)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) In Vitro and In Silico
por: Bang, EunJin, et al.
Publicado: (2018)

Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART
por: Derache, Anne, et al.
Publicado: (2019)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

Prevalence and factors associated with adverse drug events among patients on dolutegravir-based regimen at the Immune Suppression Syndrome Clinic of Mbarara Regional Referral Hospital, Uganda: a mixed design study
por: Namulindwa, Angella, et al.
Publicado: (2022)

A great enigma of the Italian Renaissance: paleopathological study on the death of Giovanni dalle Bande Nere (1498–1526) and historical relevance of a leg amputation
por: Fornaciari, Gino, et al.
Publicado: (2014)

CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz
por: Griesel, Rulan, et al.
Publicado: (2020)

Leveraging the ART Advantage: diabetes and hypertension along the HIV care cascade in rural South Africa
por: Manne-Goehler, Jennifer, et al.
Publicado: (2017)

Correlates of physical activity among people living with and without HIV in rural Uganda
por: Mabweazara, Smart Z., et al.
Publicado: (2023)

Adverse events of raltegravir and dolutegravir
por: Elzi, Luigia, et al.
Publicado: (2017)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

The resilience of Triatoma dimidiata: An analysis of reinfestation in the Nicaraguan Chagas disease vector control program (2010–2016)
por: Yoshioka, Kota, et al.
Publicado: (2018)

Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways
por: Zhang, Chao, et al.
Publicado: (2013)

Parking : manual de diseño ambiental
por: McCluskey, Jim
Publicado: (1990)

El diseño de vías urbanas
por: McCluskey, Jim
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_0c3e8in1g33b7qihc3nbpogjob